The University of Chicago Header Logo

Mark Talamonti

Concepts (729)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreatic Neoplasms
85
2023
634
10.700
Why?
Pancreatectomy
37
2023
147
4.600
Why?
Psoriasis
14
2020
235
4.540
Why?
Adenocarcinoma
45
2019
1155
4.060
Why?
Pancreaticoduodenectomy
24
2023
78
3.520
Why?
Carcinoma, Pancreatic Ductal
21
2022
101
3.110
Why?
Dermatologic Agents
7
2019
70
2.570
Why?
Liver Neoplasms
16
2023
695
1.870
Why?
Laparoscopy
18
2023
739
1.790
Why?
HLA-C Antigens
3
2017
21
1.700
Why?
Aged
110
2023
18159
1.650
Why?
Antibodies, Monoclonal, Humanized
12
2021
918
1.610
Why?
Ustekinumab
4
2019
44
1.600
Why?
Neuroendocrine Tumors
9
2023
98
1.550
Why?
Middle Aged
113
2023
24751
1.540
Why?
Neoplasm Staging
33
2018
1929
1.390
Why?
Humans
200
2023
84493
1.340
Why?
Antibodies, Monoclonal
9
2018
1366
1.320
Why?
Bile Duct Neoplasms
4
2021
74
1.270
Why?
Pancreatic Fistula
7
2023
16
1.240
Why?
Postoperative Complications
20
2023
2172
1.240
Why?
Male
123
2023
40460
1.230
Why?
Robotic Surgical Procedures
9
2023
264
1.210
Why?
Retrospective Studies
60
2023
8152
1.180
Why?
Female
124
2023
43911
1.180
Why?
Carcinoma
7
2012
431
1.160
Why?
Colorectal Neoplasms
13
2023
903
1.110
Why?
Biliary Tract Neoplasms
3
2012
31
1.090
Why?
Treatment Outcome
50
2023
7829
1.090
Why?
Interleukin-17
3
2020
98
1.050
Why?
Venous Thromboembolism
3
2023
145
0.990
Why?
Deoxycytidine
10
2018
237
0.970
Why?
Ampulla of Vater
4
2014
22
0.940
Why?
Adult
63
2023
25287
0.890
Why?
Antineoplastic Combined Chemotherapy Protocols
15
2023
2401
0.870
Why?
Aged, 80 and over
37
2021
6457
0.850
Why?
Portal Vein
2
2021
115
0.830
Why?
Hepatectomy
8
2023
160
0.820
Why?
Pancreatic Diseases
4
2020
51
0.820
Why?
Endosonography
3
2015
95
0.820
Why?
Rectal Neoplasms
5
2007
107
0.790
Why?
Survival Analysis
25
2017
1535
0.790
Why?
Neoadjuvant Therapy
11
2016
307
0.790
Why?
Pancreatic Cyst
5
2009
27
0.790
Why?
Thrombosis
2
2023
286
0.770
Why?
General Surgery
2
2022
225
0.760
Why?
Biological Therapy
1
2020
45
0.750
Why?
Organizational Innovation
2
2020
40
0.750
Why?
Drug Eruptions
1
2020
35
0.740
Why?
Stents
4
2021
366
0.730
Why?
Acrodermatitis
1
2019
3
0.720
Why?
Societies, Medical
3
2020
571
0.700
Why?
Severity of Illness Index
10
2021
1756
0.680
Why?
Diffusion of Innovation
1
2019
71
0.680
Why?
Venous Thrombosis
1
2021
241
0.680
Why?
Surgical Wound Infection
4
2023
178
0.680
Why?
Endovascular Procedures
1
2021
207
0.670
Why?
Stomach Neoplasms
5
2016
261
0.670
Why?
Adalimumab
2
2018
78
0.670
Why?
Postoperative Hemorrhage
3
2017
44
0.660
Why?
Length of Stay
9
2023
683
0.640
Why?
Drainage
3
2015
151
0.620
Why?
Survival Rate
24
2018
1852
0.620
Why?
Prognosis
26
2016
3626
0.610
Why?
Lymph Node Excision
8
2016
208
0.610
Why?
Cholangiocarcinoma
4
2021
62
0.610
Why?
Colonic Neoplasms
9
2021
545
0.600
Why?
Dermatitis, Atopic
2
2021
45
0.600
Why?
Preoperative Care
8
2017
389
0.570
Why?
Pancreatitis
5
2015
83
0.570
Why?
Alleles
2
2017
1120
0.570
Why?
Adenocarcinoma, Mucinous
2
2007
47
0.570
Why?
Education, Medical
1
2019
230
0.560
Why?
Learning
1
2019
270
0.560
Why?
Pancreas
8
2023
234
0.550
Why?
Intestinal Neoplasms
2
2009
55
0.550
Why?
Risk Factors
23
2023
5313
0.540
Why?
Chemotherapy, Adjuvant
15
2017
457
0.530
Why?
Mass Screening
2
2015
610
0.530
Why?
Biomarkers, Tumor
11
2014
1450
0.530
Why?
Antimetabolites, Antineoplastic
6
2018
236
0.530
Why?
Embolization, Therapeutic
2
2014
221
0.520
Why?
Radiotherapy, Adjuvant
12
2018
290
0.520
Why?
Mesenteric Veins
4
2021
33
0.520
Why?
Regional Health Planning
2
2014
13
0.520
Why?
Registries
6
2017
691
0.500
Why?
Hepatic Artery
1
2014
80
0.500
Why?
Surgery, Computer-Assisted
1
2015
98
0.490
Why?
Cornified Envelope Proline-Rich Proteins
1
2013
6
0.490
Why?
Carcinoma, Papillary
4
2007
158
0.480
Why?
Combined Modality Therapy
16
2016
1651
0.480
Why?
Patient Readmission
4
2017
311
0.470
Why?
Databases, Factual
10
2017
793
0.440
Why?
United States
28
2023
6474
0.440
Why?
Prospective Studies
10
2023
4091
0.440
Why?
Proportional Hazards Models
11
2017
855
0.430
Why?
Barrett Esophagus
5
2018
92
0.430
Why?
Early Detection of Cancer
2
2015
375
0.430
Why?
Cohort Studies
11
2020
2719
0.420
Why?
Quality Indicators, Health Care
2
2010
143
0.420
Why?
Safety-Based Drug Withdrawals
1
2011
2
0.410
Why?
Radiotherapy, Conformal
2
2011
88
0.410
Why?
Lymph Nodes
7
2016
534
0.400
Why?
Carcinoma, Hepatocellular
3
2018
363
0.390
Why?
Esophageal Neoplasms
8
2018
319
0.390
Why?
Young Adult
12
2021
5883
0.390
Why?
Withholding Treatment
1
2011
111
0.380
Why?
Carcinoid Tumor
4
2002
39
0.380
Why?
SEER Program
3
2014
184
0.380
Why?
Surgeons
3
2023
218
0.370
Why?
Health Care Costs
2
2017
231
0.370
Why?
Follow-Up Studies
16
2018
3598
0.370
Why?
Quality of Health Care
2
2010
377
0.360
Why?
Intestine, Small
2
2009
301
0.340
Why?
Logistic Models
9
2020
1168
0.340
Why?
Endoscopy, Gastrointestinal
2
2018
150
0.330
Why?
Neoplasm, Residual
2
2016
158
0.330
Why?
Multivariate Analysis
9
2019
994
0.330
Why?
Angiogenesis Inhibitors
1
2010
301
0.330
Why?
Hospitals, Veterans
1
2007
17
0.330
Why?
Hospital Bed Capacity
1
2007
20
0.320
Why?
Minimally Invasive Surgical Procedures
5
2023
228
0.310
Why?
Age Factors
5
2018
1827
0.310
Why?
Neoplasms
8
2023
2809
0.310
Why?
DNA-Binding Proteins
1
2013
1202
0.310
Why?
Incidence
10
2022
1559
0.310
Why?
Hospitals
5
2019
276
0.300
Why?
Patient Selection
4
2014
684
0.290
Why?
Cholangitis
1
2006
18
0.290
Why?
Hospital Costs
3
2017
102
0.280
Why?
Time Factors
9
2018
5181
0.280
Why?
Fluorouracil
10
2023
555
0.280
Why?
Diagnostic Techniques and Procedures
1
2005
24
0.270
Why?
Delivery of Health Care
1
2010
387
0.270
Why?
Gastrectomy
2
2016
66
0.270
Why?
Disposable Equipment
2
2015
17
0.260
Why?
Risk Assessment
5
2019
2230
0.260
Why?
Skin
2
2020
554
0.260
Why?
CA-19-9 Antigen
3
2014
11
0.260
Why?
Hospitals, Community
3
2010
31
0.250
Why?
Gallbladder Neoplasms
2
2020
22
0.250
Why?
Insurance Claim Review
1
2004
40
0.250
Why?
MicroRNAs
2
2023
531
0.240
Why?
Rectum
1
2004
144
0.240
Why?
Liver Transplantation
3
2018
1247
0.240
Why?
Drug Administration Schedule
6
2017
917
0.240
Why?
Cefoxitin
1
2023
3
0.240
Why?
Esophagectomy
3
2012
84
0.240
Why?
Biliary Tract Surgical Procedures
1
2023
10
0.240
Why?
Internship and Residency
2
2023
985
0.240
Why?
Chemoradiotherapy
3
2016
304
0.230
Why?
Rectus Abdominis
2
2017
36
0.230
Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2023
16
0.230
Why?
Benzoates
4
2007
45
0.230
Why?
Mortality
1
2004
148
0.230
Why?
Bevacizumab
3
2018
276
0.220
Why?
Diagnosis, Differential
6
2015
1536
0.220
Why?
Immunosuppressive Agents
3
2021
967
0.220
Why?
Cecal Neoplasms
1
2002
5
0.220
Why?
Biliary Tract Diseases
1
2022
33
0.220
Why?
Chronic Disease
3
2020
954
0.220
Why?
Anus Neoplasms
3
2011
29
0.220
Why?
Neoplasm Metastasis
5
2013
1054
0.220
Why?
Ileal Neoplasms
1
2002
9
0.220
Why?
Common Bile Duct Neoplasms
1
2001
6
0.210
Why?
Endoscopy, Digestive System
2
2012
65
0.210
Why?
Italy
2
2020
104
0.210
Why?
Simulation Training
1
2023
88
0.210
Why?
Situs Inversus
1
2001
13
0.210
Why?
Bile Ducts, Extrahepatic
2
2012
12
0.210
Why?
Genotype
2
2017
1845
0.210
Why?
Algorithms
4
2018
1812
0.210
Why?
Gastric Bypass
1
2023
109
0.210
Why?
Chemoradiotherapy, Adjuvant
3
2018
35
0.210
Why?
Infliximab
3
2018
150
0.210
Why?
Obesity, Morbid
2
2023
217
0.210
Why?
Gene Expression Regulation, Neoplastic
6
2010
1196
0.200
Why?
Eczema
1
2021
5
0.200
Why?
Tomography, X-Ray Computed
8
2017
2507
0.200
Why?
Anastomosis, Surgical
5
2016
263
0.200
Why?
Palliative Care
5
2007
247
0.200
Why?
Sigmoidoscopy
1
2001
36
0.200
Why?
Models, Theoretical
1
2004
476
0.200
Why?
Nurse Practitioners
1
2001
31
0.200
Why?
Adolescent
12
2021
8849
0.190
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2020
57
0.190
Why?
Cell Cycle
3
2007
502
0.190
Why?
Etanercept
2
2018
32
0.190
Why?
Drug Substitution
2
2018
25
0.190
Why?
Thyroid Neoplasms
4
2020
404
0.190
Why?
Europe
2
2019
305
0.190
Why?
Biological Products
2
2013
136
0.190
Why?
Surgical Oncology
1
2020
26
0.190
Why?
Genetic Markers
3
2017
476
0.190
Why?
Chemoembolization, Therapeutic
4
2009
33
0.190
Why?
Gastrointestinal Neoplasms
3
2001
102
0.190
Why?
Emergencies
1
2020
109
0.190
Why?
Robotics
1
2023
265
0.190
Why?
Cystic Fibrosis
1
2020
112
0.190
Why?
Colonic Polyps
2
2008
125
0.180
Why?
Cancer Care Facilities
2
2010
28
0.180
Why?
Personnel Selection
1
2020
59
0.180
Why?
Sepsis
1
2023
288
0.180
Why?
Neoplasm Invasiveness
6
2012
543
0.180
Why?
Cell Proliferation
6
2008
1566
0.180
Why?
Specialties, Surgical
1
2020
62
0.180
Why?
Lymphatic Metastasis
8
2008
480
0.180
Why?
Fellowships and Scholarships
1
2020
105
0.170
Why?
Interviews as Topic
1
2020
318
0.170
Why?
Kaplan-Meier Estimate
5
2018
856
0.170
Why?
Arachidonate 5-Lipoxygenase
3
2008
22
0.170
Why?
User-Computer Interface
1
2020
185
0.170
Why?
Steroids
1
2020
169
0.170
Why?
Neoplasm Recurrence, Local
6
2014
1262
0.170
Why?
Yttrium Radioisotopes
2
2009
40
0.170
Why?
Propensity Score
4
2020
136
0.170
Why?
Adenoma
3
2008
231
0.170
Why?
Education, Medical, Continuing
2
2015
106
0.170
Why?
Conversion to Open Surgery
1
2018
11
0.170
Why?
Carcinoma, Ductal, Breast
2
1997
157
0.160
Why?
Comorbidity
3
2021
934
0.160
Why?
Radiotherapy
4
2012
328
0.160
Why?
Mutation
4
2023
3904
0.160
Why?
Gene Expression Profiling
3
2018
1363
0.160
Why?
Thyroidectomy
3
2007
169
0.160
Why?
Carcinoma in Situ
2
2005
52
0.160
Why?
Gene Amplification
1
2018
131
0.160
Why?
Reoperation
3
2017
585
0.160
Why?
Liver
2
2017
1208
0.160
Why?
Databases as Topic
2
2007
92
0.160
Why?
Receptors, Calcitriol
1
2018
129
0.160
Why?
Nuclear Proteins
2
1999
688
0.150
Why?
Predictive Value of Tests
5
2014
1647
0.150
Why?
Stromal Cells
2
2015
142
0.150
Why?
Laparotomy
1
2017
58
0.150
Why?
Evidence-Based Medicine
1
2020
425
0.150
Why?
Receptors, Interleukin-17
1
2016
10
0.150
Why?
Incidental Findings
1
2017
94
0.150
Why?
Abdominal Wall
1
2017
30
0.150
Why?
Dyslipidemias
1
2018
109
0.150
Why?
Pylorus
2
2007
14
0.150
Why?
Muscular Atrophy
1
2017
38
0.150
Why?
Stomach
2
2012
109
0.150
Why?
Longitudinal Studies
2
2018
986
0.150
Why?
Metabolic Syndrome
1
2018
138
0.150
Why?
Proto-Oncogene Proteins pp60(c-src)
2
1993
12
0.150
Why?
Vascular Surgical Procedures
1
2017
149
0.150
Why?
Electric Impedance
1
2016
102
0.150
Why?
Antineoplastic Agents
4
2016
2329
0.150
Why?
Guideline Adherence
4
2017
223
0.140
Why?
Disease-Free Survival
4
2017
1204
0.140
Why?
Tetradecanoylphorbol Acetate
2
2006
137
0.140
Why?
Cell Line, Tumor
10
2018
2395
0.140
Why?
Drug Resistance
1
2016
256
0.140
Why?
Gastroesophageal Reflux
2
2015
113
0.140
Why?
Lymphoma
2
2002
259
0.130
Why?
Pneumonia, Viral
1
2020
309
0.130
Why?
Feasibility Studies
4
2016
742
0.130
Why?
Coronavirus Infections
1
2020
294
0.130
Why?
Academic Medical Centers
2
2007
372
0.130
Why?
Benchmarking
2
2008
78
0.130
Why?
Cell Division
6
2007
696
0.130
Why?
Membrane Proteins
4
2005
1181
0.130
Why?
Remission, Spontaneous
1
2014
53
0.130
Why?
Cholecystectomy, Laparoscopic
1
2014
48
0.130
Why?
Herniorrhaphy
1
2015
77
0.120
Why?
Gene Frequency
1
2016
674
0.120
Why?
Mitogen-Activated Protein Kinases
2
2005
222
0.120
Why?
Hernia, Inguinal
1
2015
66
0.120
Why?
Genetic Predisposition to Disease
3
2018
2249
0.120
Why?
Operating Rooms
1
2014
125
0.120
Why?
Magnetic Resonance Imaging
4
2015
3351
0.120
Why?
Neutropenia
2
2011
213
0.120
Why?
Margins of Excision
3
2018
37
0.120
Why?
Cost-Benefit Analysis
3
2017
442
0.120
Why?
Quality Improvement
1
2017
411
0.120
Why?
Interleukin-23
1
2013
53
0.120
Why?
Trisaccharides
1
2012
12
0.120
Why?
Immunotherapy, Active
1
2012
15
0.110
Why?
Interleukin-12
1
2013
102
0.110
Why?
Urinary Bladder Neoplasms
2
1993
359
0.110
Why?
Hemorrhage
1
2014
249
0.110
Why?
Quality Control
1
2012
118
0.110
Why?
Jaundice, Obstructive
1
2012
10
0.110
Why?
Radiopharmaceuticals
2
2012
176
0.110
Why?
Practice Guidelines as Topic
1
2020
1027
0.110
Why?
Gallbladder
1
2012
27
0.110
Why?
Nausea
2
2011
172
0.110
Why?
Adipocytes, White
1
2012
2
0.110
Why?
Arthritis, Psoriatic
1
2012
30
0.110
Why?
Ischemic Preconditioning
1
2012
37
0.110
Why?
Electroporation
1
2012
55
0.110
Why?
Gene Deletion
1
2013
327
0.110
Why?
Serpins
1
2012
29
0.110
Why?
Organoplatinum Compounds
3
2017
94
0.110
Why?
Bile Ducts, Intrahepatic
1
2012
65
0.110
Why?
Protein-Tyrosine Kinases
2
1993
302
0.110
Why?
Leucovorin
3
2017
218
0.110
Why?
Ablation Techniques
1
2012
34
0.110
Why?
Esophagus
1
2012
101
0.110
Why?
Spectrum Analysis
1
2012
118
0.110
Why?
Operative Time
3
2017
125
0.110
Why?
Nerve Growth Factors
1
2012
63
0.110
Why?
Sex Factors
4
2014
1041
0.100
Why?
Radiology, Interventional
1
2012
69
0.100
Why?
Lipoxygenase Inhibitors
2
2008
33
0.100
Why?
Ultrasonography, Interventional
1
2012
118
0.100
Why?
Microspheres
2
2009
95
0.100
Why?
Photochemotherapy
1
2012
96
0.100
Why?
Arteries
1
2012
169
0.100
Why?
Disease Progression
5
2018
1504
0.100
Why?
Camptothecin
3
2017
189
0.100
Why?
Leukopenia
1
2011
65
0.100
Why?
Ileus
1
2011
9
0.100
Why?
Cancer Vaccines
1
2012
155
0.100
Why?
Abdominal Abscess
1
2011
20
0.100
Why?
Clinical Trials as Topic
1
2016
1161
0.100
Why?
Proto-Oncogene Proteins p21(ras)
1
2012
144
0.100
Why?
Brachytherapy
1
2012
123
0.100
Why?
Biopsy
5
2009
1144
0.100
Why?
Appointments and Schedules
1
2011
53
0.100
Why?
Chromosome Aberrations
1
2012
385
0.100
Why?
Receptors, Leukotriene B4
2
2007
4
0.100
Why?
Methotrexate
1
2011
249
0.100
Why?
Immunohistochemistry
9
2009
1747
0.100
Why?
Treatment Failure
2
2009
283
0.100
Why?
Intestinal Obstruction
1
2011
88
0.100
Why?
G2 Phase
2
2006
33
0.090
Why?
Cyclosporine
1
2011
234
0.090
Why?
Health Services Needs and Demand
1
2011
101
0.090
Why?
Mucin 5AC
1
2009
8
0.090
Why?
Mucin-2
1
2009
12
0.090
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2012
236
0.090
Why?
Mucin-1
1
2009
44
0.090
Why?
Pancreatic Ducts
2
1999
24
0.090
Why?
Spleen
1
2011
430
0.090
Why?
Waiting Lists
1
2011
172
0.090
Why?
Learning Curve
2
2022
18
0.090
Why?
Adrenal Cortex Hormones
1
2021
257
0.090
Why?
Pancreatitis, Chronic
1
2010
49
0.090
Why?
Hypertension
1
2018
1116
0.090
Why?
Duodenal Neoplasms
1
2009
19
0.090
Why?
Sarcoma
2
2002
210
0.090
Why?
Remission Induction
1
2011
709
0.090
Why?
Safety
2
2010
152
0.090
Why?
Polymorphism, Genetic
1
2013
818
0.090
Why?
Vitamin D
3
2018
260
0.090
Why?
Maximum Tolerated Dose
2
2010
271
0.090
Why?
Clinical Competence
3
2023
747
0.090
Why?
DNA Methylation
3
2010
607
0.090
Why?
Illinois
3
2015
459
0.090
Why?
Breast Neoplasms
3
1999
2845
0.090
Why?
Ischemia
1
2011
238
0.090
Why?
Radiotherapy Dosage
2
2011
490
0.090
Why?
Carcinoma, Acinar Cell
1
2008
11
0.090
Why?
S Phase
2
2007
62
0.090
Why?
Animals
11
2016
26197
0.090
Why?
Research Design
3
2009
582
0.090
Why?
Chicago
2
2020
1366
0.090
Why?
Hepatocyte Nuclear Factor 1-beta
1
2008
34
0.090
Why?
Socioeconomic Factors
2
2008
551
0.080
Why?
Neoplasms, Squamous Cell
1
2008
19
0.080
Why?
Curriculum
2
2023
534
0.080
Why?
Esophagogastric Junction
1
2008
34
0.080
Why?
Gastroscopy
1
2007
23
0.080
Why?
Sentinel Lymph Node Biopsy
1
2008
61
0.080
Why?
Gastrointestinal Stromal Tumors
1
2007
23
0.080
Why?
Adenocarcinoma, Clear Cell
1
2008
62
0.080
Why?
Diagnostic Imaging
1
2012
459
0.080
Why?
Apoptosis
4
2008
1669
0.080
Why?
Catheter Ablation
1
2010
226
0.080
Why?
Leukotriene Antagonists
1
2007
25
0.080
Why?
Apigenin
1
2006
7
0.080
Why?
Hemothorax
1
1987
13
0.080
Why?
Stilbenes
1
2007
24
0.080
Why?
Referral and Consultation
1
2010
323
0.080
Why?
Disease Models, Animal
2
2008
2208
0.080
Why?
Dose-Response Relationship, Drug
4
2006
1955
0.080
Why?
Hospitals, Teaching
1
2007
114
0.080
Why?
Quality Assurance, Health Care
1
2008
222
0.070
Why?
Workload
2
2023
127
0.070
Why?
Adenoma, Islet Cell
2
2007
28
0.070
Why?
Mitosis
1
2006
149
0.070
Why?
Bone Morphogenetic Proteins
1
2007
125
0.070
Why?
Guidelines as Topic
1
2007
162
0.070
Why?
Leukotriene B4
1
2005
12
0.070
Why?
Depsipeptides
1
2006
29
0.070
Why?
Neoplasm Seeding
1
2005
16
0.070
Why?
Patient Compliance
1
2007
220
0.070
Why?
Surgical Flaps
1
2008
246
0.070
Why?
Ultrasonography
2
2012
674
0.070
Why?
Epithelium
1
2006
316
0.070
Why?
Cystadenocarcinoma
2
1995
12
0.070
Why?
Odds Ratio
1
2007
673
0.070
Why?
Phosphorylation
4
2006
1094
0.070
Why?
Bariatric Surgery
1
2008
193
0.070
Why?
Cyclooxygenase 2
1
2005
99
0.070
Why?
Blotting, Western
4
2012
777
0.070
Why?
Postoperative Care
2
2017
218
0.070
Why?
Reference Values
2
1999
672
0.070
Why?
Tissue Inhibitor of Metalloproteinase-1
1
2004
17
0.070
Why?
Antineoplastic Agents, Phytogenic
1
2007
276
0.070
Why?
Diagnostic Errors
1
2006
158
0.060
Why?
Proto-Oncogene Proteins c-bcl-2
2
2007
187
0.060
Why?
Actuarial Analysis
2
2002
66
0.060
Why?
Phosphatidylinositol 3-Kinases
1
2005
254
0.060
Why?
Drug Synergism
1
2005
302
0.060
Why?
Pilot Projects
2
2017
822
0.060
Why?
Gene Expression Regulation, Enzymologic
1
2005
211
0.060
Why?
Infusions, Intra-Arterial
2
2008
32
0.060
Why?
Fatal Outcome
1
2004
290
0.060
Why?
Melanoma
1
2008
443
0.060
Why?
RNA, Messenger
4
2018
1966
0.060
Why?
Factor V
1
2023
10
0.060
Why?
Soft Tissue Neoplasms
1
2004
126
0.060
Why?
Prothrombin
1
2023
18
0.060
Why?
Piperacillin
1
2023
7
0.060
Why?
Penicillanic Acid
1
2023
11
0.060
Why?
Radiography
1
2005
801
0.060
Why?
Demography
1
2004
170
0.060
Why?
Cholecystectomy
1
2023
18
0.060
Why?
Social Class
1
2004
125
0.060
Why?
Skin Neoplasms
1
2008
537
0.060
Why?
Protein Kinases
2
1996
205
0.060
Why?
Capillaries
1
2003
91
0.060
Why?
Anastomosis, Roux-en-Y
1
2023
26
0.060
Why?
Case-Control Studies
2
2006
1787
0.060
Why?
Cyclin A
3
2007
28
0.060
Why?
Hyaluronan Receptors
1
2002
35
0.060
Why?
Cytoreduction Surgical Procedures
1
2023
64
0.060
Why?
Hyperparathyroidism
1
2002
67
0.060
Why?
Heparin, Low-Molecular-Weight
1
2022
29
0.060
Why?
Colectomy
3
2008
160
0.060
Why?
Carcinoembryonic Antigen
2
1999
40
0.060
Why?
Parathyroid Neoplasms
1
2002
54
0.060
Why?
Parathyroidectomy
1
2002
77
0.050
Why?
Bile
1
2022
53
0.050
Why?
Endoscopy
1
2005
323
0.050
Why?
Immunoenzyme Techniques
3
2008
303
0.050
Why?
Cadherins
1
2002
150
0.050
Why?
Regression Analysis
2
2017
599
0.050
Why?
Cardiac Surgical Procedures
1
1987
456
0.050
Why?
Bone Neoplasms
1
2004
322
0.050
Why?
Biopsy, Needle
2
2009
232
0.050
Why?
Cell Cycle Proteins
2
2006
381
0.050
Why?
Thymidylate Synthase
1
2001
13
0.050
Why?
Cholangiopancreatography, Endoscopic Retrograde
1
2001
59
0.050
Why?
Consensus
1
2023
318
0.050
Why?
Outpatient Clinics, Hospital
1
2001
23
0.050
Why?
Credentialing
1
2001
14
0.050
Why?
Marketing of Health Services
1
2001
15
0.050
Why?
DNA, Neoplasm
2
2006
266
0.050
Why?
Midwestern United States
1
2001
74
0.050
Why?
Cisplatin
3
2011
603
0.050
Why?
Dose-Response Relationship, Radiation
1
2000
189
0.050
Why?
United Kingdom
1
2020
163
0.050
Why?
Biological Specimen Banks
1
2020
63
0.050
Why?
Neovascularization, Pathologic
1
2002
353
0.050
Why?
Sensitivity and Specificity
2
2009
1971
0.050
Why?
Surgical Procedures, Operative
2
2011
182
0.050
Why?
Sequence Deletion
1
2020
203
0.050
Why?
Leiomyomatosis
1
2000
12
0.050
Why?
Florida
1
2020
53
0.050
Why?
Morbidity
1
2020
144
0.050
Why?
Pharyngeal Neoplasms
1
1999
13
0.050
Why?
Untranslated Regions
1
2019
19
0.050
Why?
Infusions, Intravenous
1
2000
429
0.050
Why?
Bronchi
1
2020
227
0.050
Why?
Nuclear Matrix-Associated Proteins
1
1999
13
0.050
Why?
ROC Curve
2
2014
746
0.050
Why?
Antigens, Nuclear
1
1999
25
0.050
Why?
Reagent Kits, Diagnostic
1
1999
39
0.040
Why?
Anticoagulants
1
2022
400
0.040
Why?
Adenomatous Polyposis Coli
1
1999
38
0.040
Why?
Open Reading Frames
1
2019
117
0.040
Why?
Immunoassay
1
1999
91
0.040
Why?
Congresses as Topic
1
2020
116
0.040
Why?
Genetic Counseling
1
1999
96
0.040
Why?
Tumor Suppressor Protein p53
1
2001
370
0.040
Why?
Program Evaluation
1
2020
295
0.040
Why?
Pharmacogenomic Testing
1
2019
96
0.040
Why?
Class II Phosphatidylinositol 3-Kinases
1
2018
8
0.040
Why?
Autoantigens
1
1999
124
0.040
Why?
Lymphoma, Non-Hodgkin
1
2020
259
0.040
Why?
Statistics, Nonparametric
2
2009
306
0.040
Why?
Chi-Square Distribution
2
2009
358
0.040
Why?
Flow Cytometry
3
2007
673
0.040
Why?
Intention to Treat Analysis
1
2018
71
0.040
Why?
Anti-Bacterial Agents
1
2023
716
0.040
Why?
Filgrastim
1
2017
56
0.040
Why?
Cryosurgery
1
1998
38
0.040
Why?
Gastrointestinal Diseases
1
1999
144
0.040
Why?
Receptor, Notch1
1
2018
84
0.040
Why?
Tumor Cells, Cultured
3
2008
1041
0.040
Why?
Radiography, Abdominal
1
2017
68
0.040
Why?
Neoplasms, Second Primary
1
2000
249
0.040
Why?
Blood Loss, Surgical
1
2017
110
0.040
Why?
Hernia, Ventral
1
2017
24
0.040
Why?
Incisional Hernia
1
2017
17
0.040
Why?
Prolactinoma
1
1997
8
0.040
Why?
Nucleic Acid Synthesis Inhibitors
2
2007
15
0.040
Why?
Cyclin E
2
2007
27
0.040
Why?
Cyclin B
2
2006
17
0.040
Why?
Clinical Trials, Phase II as Topic
1
1998
173
0.040
Why?
Betacoronavirus
1
2020
252
0.040
Why?
Animals, Genetically Modified
1
1997
180
0.040
Why?
Genetic Engineering
1
1997
113
0.040
Why?
Shock, Septic
1
2017
94
0.040
Why?
Breast Neoplasms, Male
1
1997
30
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2008
872
0.040
Why?
Serum Albumin
1
2017
130
0.040
Why?
Blood Transfusion
1
2017
154
0.040
Why?
Models, Economic
1
2017
60
0.040
Why?
Atrophy
1
2017
109
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2007
73
0.040
Why?
Pituitary Neoplasms
1
1997
62
0.040
Why?
Body Composition
1
2016
65
0.040
Why?
Molecular Sequence Data
4
2005
3025
0.040
Why?
Neoplasms, Multiple Primary
1
1997
102
0.040
Why?
Oligonucleotide Array Sequence Analysis
2
2010
684
0.040
Why?
Vascular Endothelial Growth Factor A
1
2018
394
0.040
Why?
Capecitabine
1
2016
87
0.040
Why?
Promoter Regions, Genetic
1
1999
928
0.040
Why?
Zonula Occludens-2 Protein
3
2000
10
0.040
Why?
Data Collection
1
2017
363
0.040
Why?
Drug Therapy, Combination
1
2018
887
0.040
Why?
Antineoplastic Agents, Immunological
1
2018
185
0.040
Why?
Cystadenoma, Mucinous
1
1995
7
0.040
Why?
Cystadenoma, Serous
1
1995
15
0.040
Why?
Butadienes
2
2005
33
0.030
Why?
RNA Helicases
1
1996
33
0.030
Why?
Mice
5
2012
11056
0.030
Why?
Flavonoids
2
2006
85
0.030
Why?
Genetic Heterogeneity
1
2015
62
0.030
Why?
Heterografts
1
2015
99
0.030
Why?
Cost Control
1
2015
43
0.030
Why?
Genes, Tumor Suppressor
1
1996
157
0.030
Why?
Polyethylene Glycols
1
2017
359
0.030
Why?
Nitriles
2
2005
143
0.030
Why?
Keratin-19
1
2014
9
0.030
Why?
Mice, Nude
2
2008
787
0.030
Why?
Cystadenoma
1
1994
19
0.030
Why?
Inhibitor of Apoptosis Proteins
1
2014
33
0.030
Why?
Proton Pump Inhibitors
1
2015
32
0.030
Why?
Ki-67 Antigen
1
2014
60
0.030
Why?
Radiotherapy, Intensity-Modulated
1
2016
182
0.030
Why?
Patient Care Planning
1
2015
81
0.030
Why?
Proto-Oncogene Proteins c-kit
1
2014
79
0.030
Why?
Neoplasm Regression, Spontaneous
1
2014
7
0.030
Why?
Perioperative Care
1
2016
157
0.030
Why?
Clinical Trials, Phase III as Topic
1
2015
166
0.030
Why?
Adipose Tissue
1
2016
237
0.030
Why?
Mastectomy
1
1996
233
0.030
Why?
Gene Expression
2
2015
1277
0.030
Why?
Surgical Mesh
1
2015
113
0.030
Why?
Pandemics
1
2020
704
0.030
Why?
Double-Blind Method
1
2018
1806
0.030
Why?
Breast
1
1996
286
0.030
Why?
Postoperative Period
1
2014
301
0.030
Why?
Bone Density Conservation Agents
1
2014
45
0.030
Why?
DNA
2
2010
1275
0.030
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2015
230
0.030
Why?
Phosphopyruvate Hydratase
1
1993
39
0.030
Why?
Mammography
1
1996
457
0.030
Why?
Body Mass Index
1
2016
766
0.030
Why?
Antigen-Antibody Complex
1
1993
84
0.030
Why?
Jejunostomy
1
2012
14
0.030
Why?
Ligation
1
2012
50
0.030
Why?
Gastric Emptying
1
2012
23
0.030
Why?
Population Surveillance
1
2014
219
0.030
Why?
Blood Sedimentation
1
2012
13
0.030
Why?
Celiac Artery
1
2012
23
0.030
Why?
Synovial Membrane
1
2012
27
0.030
Why?
Analysis of Variance
1
2014
916
0.030
Why?
Immunoblotting
1
1993
266
0.030
Why?
Cell Transformation, Neoplastic
1
2015
424
0.030
Why?
Genetic Variation
1
2019
1345
0.030
Why?
Bone Resorption
1
2012
41
0.030
Why?
Rats
3
2005
3968
0.030
Why?
Rats, Sprague-Dawley
2
2005
1205
0.030
Why?
Enteral Nutrition
1
2012
103
0.030
Why?
Practice Patterns, Physicians'
1
2017
574
0.030
Why?
Matrix Metalloproteinase 2
1
2012
44
0.030
Why?
Cricetinae
2
2005
560
0.030
Why?
Matrix Metalloproteinase 9
1
2012
77
0.030
Why?
Adiposity
1
2012
68
0.030
Why?
Constriction, Pathologic
1
2012
206
0.030
Why?
Mitomycin
1
2011
29
0.030
Why?
C-Reactive Protein
1
2012
189
0.030
Why?
Anastomotic Leak
1
2012
95
0.030
Why?
Benzodiazepines
1
2011
64
0.020
Why?
Randomized Controlled Trials as Topic
1
2015
831
0.020
Why?
Real-Time Polymerase Chain Reaction
1
2012
268
0.020
Why?
Eye Proteins
1
2012
128
0.020
Why?
Genome-Wide Association Study
1
2018
1594
0.020
Why?
Validation Studies as Topic
1
2010
16
0.020
Why?
Intestinal Perforation
1
1990
32
0.020
Why?
Tissue Array Analysis
1
2010
124
0.020
Why?
Health Care Surveys
1
2011
277
0.020
Why?
Metaplasia
1
2009
37
0.020
Why?
Obesity
1
2016
940
0.020
Why?
Forecasting
1
2011
305
0.020
Why?
Polymorphism, Single Nucleotide
1
2018
2339
0.020
Why?
Sphincterotomy, Endoscopic
1
2009
9
0.020
Why?
CD11 Antigens
1
2009
14
0.020
Why?
Cause of Death
1
2010
273
0.020
Why?
Receptors, Androgen
1
2009
108
0.020
Why?
Radiation Injuries
1
1990
158
0.020
Why?
Receptors, Tumor Necrosis Factor
1
2009
87
0.020
Why?
Quality of Life
1
2017
1507
0.020
Why?
Masoprocol
1
2008
3
0.020
Why?
Thymidine
1
2008
58
0.020
Why?
Microarray Analysis
1
2009
96
0.020
Why?
Periodic Acid-Schiff Reaction
1
2008
6
0.020
Why?
Fluorescent Antibody Technique, Direct
1
2008
10
0.020
Why?
Pelvic Exenteration
1
2008
5
0.020
Why?
Data Interpretation, Statistical
1
2010
298
0.020
Why?
Amino Acid Sequence
2
2005
2057
0.020
Why?
Intestinal Fistula
1
2008
29
0.020
Why?
Probability
1
2009
353
0.020
Why?
Perineum
1
2008
35
0.020
Why?
Lung Neoplasms
1
2020
2235
0.020
Why?
Abdominal Cavity
1
2008
15
0.020
Why?
Antigens, Tumor-Associated, Carbohydrate
1
2007
11
0.020
Why?
Tomography, Emission-Computed
1
2008
103
0.020
Why?
Professional Practice
1
2008
45
0.020
Why?
Mice, Transgenic
2
2005
1519
0.020
Why?
Gastrointestinal Hemorrhage
1
1990
222
0.020
Why?
Gastric Outlet Obstruction
1
2007
10
0.020
Why?
Hospital Mortality
1
2010
345
0.020
Why?
Intestinal Mucosa
1
1993
785
0.020
Why?
Genes, bcl-2
1
2007
16
0.020
Why?
Caspase 7
1
2007
15
0.020
Why?
Cytochromes c
1
2007
27
0.020
Why?
Cyclin-Dependent Kinase 2
1
2007
24
0.020
Why?
Cholestasis
1
2007
44
0.020
Why?
Caspase 9
1
2007
47
0.020
Why?
Asthenia
1
2007
4
0.020
Why?
Cyclin-Dependent Kinase Inhibitor p27
1
2007
36
0.020
Why?
bcl-2-Associated X Protein
1
2007
47
0.020
Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2007
35
0.020
Why?
Poly(ADP-ribose) Polymerases
1
2007
45
0.020
Why?
Growth Differentiation Factor 15
1
2007
9
0.020
Why?
Dactinomycin
1
2007
35
0.020
Why?
cdc25 Phosphatases
1
2006
17
0.020
Why?
Immunoglobulin G
1
2009
448
0.020
Why?
Mice, Knockout
1
2012
1894
0.020
Why?
Caspase 3
1
2007
159
0.020
Why?
Surgical Wound Dehiscence
1
1987
37
0.020
Why?
Xenograft Model Antitumor Assays
1
2008
455
0.020
Why?
In Vitro Techniques
1
2008
984
0.020
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2007
69
0.020
Why?
CDC2 Protein Kinase
1
2006
45
0.020
Why?
Vagina
1
2008
157
0.020
Why?
Cyclin B1
1
2006
17
0.020
Why?
Headache
1
2007
72
0.020
Why?
Maleimides
1
2006
29
0.020
Why?
Mitogen-Activated Protein Kinase 3
1
2006
68
0.020
Why?
Mitogen-Activated Protein Kinase 1
1
2006
74
0.020
Why?
MAP Kinase Kinase Kinases
1
2006
41
0.020
Why?
Mice, Inbred BALB C
1
2008
1041
0.020
Why?
Vomiting
1
2008
188
0.020
Why?
Cell Nucleus
1
2008
574
0.020
Why?
Nitrobenzenes
1
2005
11
0.020
Why?
Nitrosamines
1
2005
8
0.020
Why?
Enzyme Activation
1
2007
689
0.020
Why?
Cyclooxygenase 2 Inhibitors
1
2005
33
0.020
Why?
Positron-Emission Tomography
1
2007
322
0.020
Why?
Electrophoresis, Polyacrylamide Gel
1
2005
267
0.020
Why?
Cell Growth Processes
1
2005
83
0.020
Why?
Tumor Necrosis Factor-alpha
1
2009
668
0.020
Why?
Base Sequence
2
1999
2321
0.020
Why?
Androstadienes
1
2005
72
0.020
Why?
Protein Kinase C
1
2006
270
0.020
Why?
NIH 3T3 Cells
1
2005
105
0.020
Why?
Disease Management
1
2007
325
0.020
Why?
Culture Media, Conditioned
1
2005
102
0.020
Why?
Coculture Techniques
1
2005
161
0.020
Why?
Carcinogens
1
2005
108
0.020
Why?
PPAR gamma
1
2005
65
0.020
Why?
RNA, Small Interfering
1
2007
542
0.020
Why?
Transfection
1
2007
892
0.020
Why?
Quinolines
1
2005
94
0.020
Why?
Random Allocation
1
2005
332
0.020
Why?
Indoles
1
2006
316
0.020
Why?
Sequence Homology, Amino Acid
1
2005
414
0.020
Why?
Neoplasm Transplantation
1
2005
393
0.020
Why?
Signal Transduction
2
2005
3198
0.020
Why?
Green Fluorescent Proteins
1
2005
302
0.020
Why?
Up-Regulation
1
2007
709
0.020
Why?
Pregnancy Complications
1
2007
336
0.020
Why?
Neoplasm Proteins
1
2007
532
0.010
Why?
Administration, Oral
1
2005
684
0.010
Why?
Cell Survival
1
2006
967
0.010
Why?
Sulfonamides
1
2005
296
0.010
Why?
Enzyme Inhibitors
1
2005
632
0.010
Why?
Transcription, Genetic
1
2007
1120
0.010
Why?
Protein Kinase Inhibitors
1
2006
588
0.010
Why?
Thyroid Gland
1
2002
263
0.010
Why?
Cell Differentiation
1
2007
1416
0.010
Why?
Cell Line
1
2006
2452
0.010
Why?
Biomarkers
1
2006
1671
0.010
Why?
Cells, Cultured
1
2005
2788
0.010
Why?
Technetium Tc 99m Sulfur Colloid
1
1999
11
0.010
Why?
Vulvar Neoplasms
1
2000
20
0.010
Why?
Pregnancy
1
2007
2820
0.010
Why?
Palpation
1
1999
18
0.010
Why?
Coloring Agents
1
1999
64
0.010
Why?
Protein Isoforms
1
2000
266
0.010
Why?
Introns
1
2000
286
0.010
Why?
Blotting, Northern
1
1999
256
0.010
Why?
Axilla
1
1999
96
0.010
Why?
Radionuclide Imaging
1
1999
217
0.010
Why?
Image Processing, Computer-Assisted
1
2005
1200
0.010
Why?
Exons
1
2000
447
0.010
Why?
Medical Staff, Hospital
1
1999
107
0.010
Why?
Proliferating Cell Nuclear Antigen
1
1997
65
0.010
Why?
Heart Failure
1
2007
1161
0.010
Why?
Gynecomastia
1
1997
8
0.010
Why?
Mastectomy, Modified Radical
1
1997
6
0.010
Why?
Genetic Techniques
1
1997
71
0.010
Why?
Microscopy, Electron
1
1997
500
0.010
Why?
Recurrence
1
1999
1128
0.010
Why?
RNA, Double-Stranded
1
1996
22
0.010
Why?
Hyperplasia
1
1996
147
0.010
Why?
DEAD-box RNA Helicases
1
1996
62
0.010
Why?
eIF-2 Kinase
1
1995
46
0.010
Why?
Precancerous Conditions
1
1996
194
0.010
Why?
Ovarian Neoplasms
1
1993
723
0.000
Why?
Talamonti's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (729)
Explore
_
Co-Authors (41)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_